Since then, a new generation CPPs have been used as vehicles to transport many different drugs and molecules through the BBB in CNS diseases, including stroke [3], but so far, we have not found new attempts to use CPPs or other nanotechnological tools as media to facilitate the passage of Ngb through the BBB nor to convey it in in vivo models of stroke. The gene discussed is NGB; the disease is Stroke.